QQQM logo

QQQM
Invesco NASDAQ 100 ETF

5,666
Volume
2.01M
52W High
$262.23
52W Low
$165.72
50D MA
$255.03
Prev Close
$251.78
Loading...
Loading...
News
all
press releases
PYPL Stock Has Shed 30% Over Past 10 Sessions – So Why Is Retail Still Bullish?
PayPal’s shares have declined for 10 consecutive sessions, falling to a level last seen around 9 years ago.
Stocktwits·5d ago
News Placeholder
More News
News Placeholder
How to Position Your ETF Portfolio for 2026
We discuss the market outlook and how investors should position their portfolios.
Zacks·30d ago
News Placeholder
Here's How Much You Would Have Made Owning Invesco NASDAQ 100 ETF Stock In The Last 5 Years
read more...
Benzinga·30d ago
News Placeholder
Should Invesco NASDAQ 100 ETF (QQQM) Be on Your Investing Radar?
Style Box ETF report for QQQM
Zacks·2mo ago
News Placeholder
QQQM ETF Factor Report
Below is Validea's ETF fundamental report for Invesco NASDAQ 100 ETF (QQQM). The report looks at QQQM's exposure to the major investing factors including value, quality, momentum and low volatility...
Nasdaq News: Markets·2mo ago
News Placeholder
If You Invested $1000 In Invesco NASDAQ 100 ETF Stock 5 Years Ago, You Would Have This Much Today
read more...
Benzinga·2mo ago
News Placeholder
Shopify Stock Rises After Hours As Recovery Signs Emerge From Cyber Monday Meltdown
The Canadian e-commerce company said on Monday morning at around 9:47 EST that merchants may experience issues when trying to login to Shopify and also when logging into point-of-sale systems or attempting to contact support.
Stocktwits·2mo ago
News Placeholder
Detailed Fundamental Analysis - QQQM
Below is Validea's ETF fundamental report for Invesco NASDAQ 100 ETF (QQQM). The report looks at QQQM's exposure to the major investing factors including value, quality, momentum and low volatility...
Nasdaq News: Markets·3mo ago
News Placeholder
QQQM ETF Factor Report
Below is Validea's ETF fundamental report for Invesco NASDAQ 100 ETF (QQQM). The report looks at QQQM's exposure to the major investing factors including value, quality, momentum and low volatility...
Nasdaq News: Markets·3mo ago
News Placeholder
AstraZeneca Says Asthma Drug Failed Trial In Smoker’s Disease
The company stated that the safety and tolerability of the drug in the recent trial were consistent with the known profile of the medicine, and added that it will analyze the data further to understand the results.
Stocktwits·5mo ago
<
1
2
...
>

Latest QQQM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.